Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain cancer. In a large-scale drug screening, the antidepressant, vortioxetine emerged as one of the most effective agents against these types of cancer cells. Clinical trials are already […]
Source link